PUBLISHER: IMARC | PRODUCT CODE: 2016104
PUBLISHER: IMARC | PRODUCT CODE: 2016104
The global industrial microbiology market size reached USD 13.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 23.0 Billion by 2034, exhibiting a growth rate (CAGR) of 6.27% during 2026-2034.
Industrial microbiology or microbial biotechnology refers to the process of manipulating microorganisms for the benefit of the environment, society, and industries. These microorganisms, which are used to produce large-scale industrial products, include naturally occurring organisms, laboratory selected mutants, and genetically modified organisms (GMO). As industrial microbiology relies on renewable resources, it assists in replacing fossil fuels, non-biodegradable plastics, and highly polluting chemical processes with biocompatible alternatives. Presently, it finds extensive application in the manufacturing of alcohols and acetone across the globe.
The flourishing pharmaceutical industry represents one of the key factors strengthening the growth of the market. Industrial microbiology assists in the development of antibiotics, vaccines, and steroids. It also aids in maintaining the overall quality and preventing microbial contamination of drugs, injectables, eye drops, nasal solutions, and inhalation products. This, in confluence with the rising demand for antibiotics, is contributing to the market growth. Additionally, depleting oil resources and increasing energy demands are catalyzing the need for cost-effective and eco-friendly oil recovery technologies. Apart from this, as industrial microbiology does not require vast energy inputs and is not impacted by crude oil prices, it finds a wide array of applications in the oil and gas industry across the globe. Moreover, it is increasingly being employed in the food and beverage (F&B) industry for producing fermented food products and the conversion of industrial food wastes into value-added products. This, coupled with the technological advancements to improve productivity, enhance organoleptic characteristics, and attribute new nutritional functions to certain foods, is creating a favorable market outlook. The market is also propelled by the expanding applications of microbiology in the cosmetics and personal care industry worldwide.
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc, Danaher Corporation, Eppendorf AG, QIAGEN, Sartorius AG, Merck KGaA and Thermo Fisher Scientific Inc.